PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDarktrace Regulatory News (DARK)

Share Price Information for Darktrace (DARK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 592.00
Bid: 592.60
Ask: 595.00
Change: -3.80 (-0.64%)
Spread: 2.40 (0.405%)
Open: 593.40
High: 593.40
Low: 592.00
Prev. Close: 595.80
DARK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management changes

19 Jul 2022 07:00

RNS Number : 8894S
Darktrace PLC
19 July 2022
 

19th July 2022

Darktrace plc

("Darktrace")

Darktrace announces additions to executive team

Three new executive team members appointed, further strengthening and deepening Darktrace's management capabilities

Two long-standing executives to step down

19 July, 2022, London: Darktrace, a global leader in cyber security AI, today announces several changes to its executive management team as it seeks to bring in further leadership capabilities in key areas including human resources and corporate affairs.

Two new executives have joined the Darktrace team. David Walden joins as Chief People Officer and Carolyn Esser joins as Chief Corporate Affairs Officer. David is responsible for global talent attraction, engagement and performance management. David has driven successful people strategies at multinational companies, including Capital One, AOL, T. Rowe Price, and Etsy. Carolyn is responsible for Darktrace's internal and external communications strategies. Carolyn joins Darktrace from the Bill & Melinda Gates Foundation where she was Deputy Director, Communications, Europe, Middle East and East Asia. Prior to that, Carolyn was Global Communications Director at Logica, the UK technology and business services company.

Two long-standing executives are leaving after years of making significant contributions to Darktrace. Emily Orton stepped down from her Chief Marketing Officer (CMO) role in early July. Following Emily's departure, the marketing functions are being reorganised to report to Carolyn Esser and Nicole Eagan, Chief Strategy and AI Officer. Dave Palmer, Chief Product Officer (CPO), will be leaving Darktrace at the end of August to join long-standing Darktrace investor, 1011 Venture Capital, as a General Partner. At his departure, Dave will join Darktrace's Advisory Council, where he will continue to advise the organisation on key industry trends. Dave will be replaced by Max Heinemeyer, currently Darktrace's VP of Cyber Innovation, who will join the executive management team as CPO.

Commenting on these changes, Poppy Gustafsson, Chief Executive Officer of Darktrace, said:

 

"Both Dave and Emily have played pivotal roles in growing Darktrace into the innovative, world-class cyber security company that it is today. Their contributions to the company have been immense and we are so grateful for their leadership over the many years they have been with us. We wish them every success in their new endeavours, and I am thrilled that Dave will remain in the Darktrace family through his role on our Advisory Council.

 

I'm delighted to welcome Max, Carolyn and David to our executive management team as we continue to strengthen and deepen our leadership capabilities in a number of core areas."

 

Important Information

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018). Upon publication of this announcement, this information is now considered in the public domain.

 

 

Enquiries:

 

Luk Janssens - Head of Investor Relations, Darktrace

Luk.janssens@darktrace.com

 

Powerscourt (Public Relations adviser to Darktrace)

Victoria Palmer-Moore/Robin O'Kelly

Direct: +44 (0) 20 3328 9386

darktrace@powerscourt-group.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUWSRRUBUBAUR
Date   Source Headline
31st Oct 20224:40 pmRNSTotal Voting Rights
27th Oct 20224:19 pmRNSTR-1: Notification of major holdings
27th Oct 20224:17 pmRNSTR-1: Notification of major holdings
27th Oct 20224:15 pmRNSTR-1: Notification of major holdings
27th Oct 202210:46 amRNSTR-1: Notification of major holdings
14th Oct 20227:00 amRNSEBT Market Purchase Programme
13th Oct 20225:20 pmRNSDirector/PDMR Shareholding
12th Oct 20227:00 amRNSQ1 FY 2023 Trading Update
6th Oct 202211:19 amRNSTR-1: Notification of major holdings
30th Sep 20224:45 pmRNSTotal Voting Rights
28th Sep 20225:57 pmRNSTR-1: Notification of major holdings
27th Sep 20225:26 pmRNSDirector/PDMR Shareholding
26th Sep 20223:32 pmRNSNotice of AGM
23rd Sep 20229:49 amRNSDirector/PDMR Shareholding
9th Sep 20223:20 pmRNSForm 8.3 - DARKTRACE PLC
9th Sep 20222:52 pmRNSForm 8.3 - Darktrace plc
9th Sep 202212:23 pmRNSForm 8.3 - Darktrace plc
9th Sep 202211:43 amRNSForm 8.5 (EPT/RI)
8th Sep 20223:20 pmRNSForm 8.3 - DARKTRACE PLC
8th Sep 20222:54 pmRNSForm 8.3 - Darktrace plc
8th Sep 20222:34 pmEQSForm 8.3 - The Vanguard Group, Inc.: Darktrace plc
8th Sep 20221:48 pmRNSForm 8.3 - Darktrace plc
8th Sep 202211:35 amRNSForm 8.5 (EPT/RI)
8th Sep 202210:34 amRNSForm 8.3 - Darktrace PLC
8th Sep 202210:04 amRNSForm 8.5 (EPT/NON-RI) - Darktrace PLC
8th Sep 20228:07 amRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
8th Sep 20227:12 amRNSOffer Talks Terminated
8th Sep 20227:00 amRNSFinal Results
8th Sep 20227:00 amRNSStatement re Darktrace
7th Sep 20225:31 pmRNSForm 8.5 (EPT/RI)-Amendment
7th Sep 20223:20 pmRNSForm 8.3 - DARKTRACE PLC
7th Sep 20222:59 pmRNSForm 8.3 - Darktrace plc
7th Sep 20222:42 pmEQSForm 8.3 - The Vanguard Group, Inc.: Darktrace plc
7th Sep 20222:38 pmRNSForm 8.3 - Darktrace plc
7th Sep 202211:32 amRNSForm 8.5 (EPT/RI)
7th Sep 202211:12 amRNSForm 8.3 - Darktrace PLC
7th Sep 202210:15 amRNSForm 8.3 - Darktrace PLC
7th Sep 202210:12 amRNSForm 8.5 (EPT/NON-RI)
7th Sep 202210:09 amRNSForm 8.3 - Darktrace plc
7th Sep 20228:24 amRNSForm 8.5 (EPT/NON-RI) Darktrace Plc
6th Sep 20223:20 pmRNSForm 8.3 - Darktrace plc
6th Sep 20222:58 pmRNSForm 8.3 - Darktrace plc
6th Sep 20222:14 pmBUSForm 8.3 - Darktrace plc
6th Sep 20221:04 pmGNWInvesco Ltd.: Form 8.3 - Darktrace PLC
6th Sep 202212:34 pmRNSForm 8.3 - Darktrace plc
6th Sep 202211:38 amRNSForm 8.3 - Darktrace PLC
6th Sep 202210:56 amRNSForm 8.3 - Darktrace plc
6th Sep 202210:26 amRNSForm 8.5 (EPT/RI)
6th Sep 202210:21 amRNSForm 8.3 - Darktrace PLC
6th Sep 20229:14 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.